Literature DB >> 7138704

Theory and practice in prevention of arterial thrombosis.

J R Mitchell.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7138704      PMCID: PMC482723          DOI: 10.1136/hrt.48.5.417

Source DB:  PubMed          Journal:  Br Heart J        ISSN: 0007-0769


× No keyword cloud information.
  18 in total

1.  PLATELET CLUMPING IN VITRO.

Authors:  J R MITCHELL; A A SHARP
Journal:  Br J Haematol       Date:  1964-01       Impact factor: 6.998

2.  Impaired platelet-connective-tissue reaction in man after aspirin ingestion.

Authors:  H J Weiss; L M Aledort
Journal:  Lancet       Date:  1967-09-02       Impact factor: 79.321

3.  The field trial: some thoughts on the indispensable ordeal.

Authors:  D S Fredrickson
Journal:  Bull N Y Acad Med       Date:  1968-08

4.  Anticoagulants in coronary heart disease--retrospect and prospect.

Authors:  J R Mitchell
Journal:  Lancet       Date:  1981-01-31       Impact factor: 79.321

5.  Effects of a selective inhibitor of thromboxane synthetase on human blood platelet behaviour.

Authors:  S Heptinstall; J Bevan; S R Cockbill; S P Hanley; M J Parry
Journal:  Thromb Res       Date:  1980-10-15       Impact factor: 3.944

Review 6.  Prostaglandins in vascular disease: a seminal approach.

Authors:  J R Mitchell
Journal:  Br Med J (Clin Res Ed)       Date:  1981-02-21

7.  Differential inhibition by low-dose aspirin of human venous prostacyclin synthesis and platelet thromboxane synthesis.

Authors:  S P Hanley; J Bevan; S R Cockbill; S Heptinstall
Journal:  Lancet       Date:  1981-05-02       Impact factor: 79.321

8.  Thromboxane synthetase inhibition as antithrombotic strategy.

Authors:  J Vermylen; G Defreyn; L O Carreras; S J Machin; J Van Schaeren; M Verstraete
Journal:  Lancet       Date:  1981-05-16       Impact factor: 79.321

9.  Haemostatic function and cardiovascular death: early results of a prospective study.

Authors:  T W Meade; W R North; R Chakrabarti; Y Stirling; A P Haines; S G Thompson; M Brozovié
Journal:  Lancet       Date:  1980-05-17       Impact factor: 79.321

10.  Thromboxanes: a new group of biologically active compounds derived from prostaglandin endoperoxides.

Authors:  M Hamberg; J Svensson; B Samuelsson
Journal:  Proc Natl Acad Sci U S A       Date:  1975-08       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.